• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福平载药漂浮微球的研制与表征

Development and characterization of rifampicin loaded floating microspheres.

作者信息

Goyal Pankaj, Gill S, Gupta U D, Rath Goutam, Narang Raj K, Goyal Amit K

机构信息

Nanomedicine Research Centre, Department of Pharmaceutics, Indo-Soviet Friendship College of Pharmacy, Moga (Punjab), India.

出版信息

Artif Cells Blood Substit Immobil Biotechnol. 2011 Oct;39(5):330-4. doi: 10.3109/10731199.2011.573482. Epub 2011 Jun 2.

DOI:10.3109/10731199.2011.573482
PMID:21631389
Abstract

Gastroretentive floating microspheres have a potential for enhancing the bioavailability and controlled delivery of drugs. The present study involves development of rifampicin floating microspheres in order to increase the gastric retention time. The microspheres were prepared by solvent evaporation technique and characterized for particle size, shape, zeta-potential, entrapment, and release kinetics. The developed systems were almost spherical in shape. The entrapment efficiency was found to be 86.34%. The percentage buoyancy after 8 hours was found to be 61.06. The prepared microspheres exhibited prolonged drug release in gastric medium and hence could be utilized for sustained delivery of anti-tubercular drugs.

摘要

胃滞留型漂浮微球具有提高药物生物利用度和控制药物释放的潜力。本研究旨在开发利福平漂浮微球,以延长药物在胃内的滞留时间。采用溶剂蒸发技术制备微球,并对其粒径、形状、ζ电位、包封率和释放动力学进行表征。所制备的微球形状近似球形,包封率为86.34%,8小时后的漂浮率为61.06%。所制备的微球在胃内介质中呈现出药物的长效释放,因此可用于抗结核药物的持续递送。

相似文献

1
Development and characterization of rifampicin loaded floating microspheres.利福平载药漂浮微球的研制与表征
Artif Cells Blood Substit Immobil Biotechnol. 2011 Oct;39(5):330-4. doi: 10.3109/10731199.2011.573482. Epub 2011 Jun 2.
2
Biodegradable anionic acrylic resin based hollow microspheres of moderately water soluble drug rosiglitazone maleate: preparation and in vitro characterization.基于可生物降解阴离子型丙烯酸树脂的马来酸罗格列酮中空微球的制备及体外特性研究。
Drug Dev Ind Pharm. 2012 Dec;38(12):1460-9. doi: 10.3109/03639045.2011.653811. Epub 2012 Feb 23.
3
Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosis.采用热凝胶法制备的利福平与蔗糖交联的明胶微球用于治疗结核病。
J Microencapsul. 2009 Feb;26(1):83-9. doi: 10.1080/02652040802172638.
4
Gelatin nanocarriers as potential vectors for effective management of tuberculosis.明胶纳米载体作为有效管理结核病的潜在载体。
Int J Pharm. 2010 Jan 29;385(1-2):143-9. doi: 10.1016/j.ijpharm.2009.10.004. Epub 2009 Oct 9.
5
Preparation of Eudragit E100 microspheres by modified solvent evaporation method.采用改良溶剂蒸发法制备聚丙烯酸树脂E100微球。
Acta Pol Pharm. 2011 Nov-Dec;68(6):975-80.
6
Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.实验模型中基于纳米颗粒的皮下抗结核化疗
J Antimicrob Chemother. 2004 Jul;54(1):266-8. doi: 10.1093/jac/dkh260. Epub 2004 May 5.
7
Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin.使用载有利福平的聚乳酸-羟基乙酸共聚物(PLGA)微球将利福平高效细胞内递送至肺泡巨噬细胞:PLGA的分子量和组成对利福平释放的影响
Colloids Surf B Biointerfaces. 2004 Jul 1;36(1):35-42. doi: 10.1016/j.colsurfb.2004.03.018.
8
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.用于实验性结核病的基于聚(DL-丙交酯-共-乙交酯)纳米颗粒的可吸入持续给药系统
J Antimicrob Chemother. 2003 Dec;52(6):981-6. doi: 10.1093/jac/dkg477. Epub 2003 Nov 12.
9
Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.响应面法优化白屈菜红碱载 O-羧甲基壳聚糖微球的处方。
Int J Biol Macromol. 2011 Dec 1;49(5):970-8. doi: 10.1016/j.ijbiomac.2011.08.019. Epub 2011 Aug 26.
10
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.西咪替丁漂浮微球:制剂、表征及体外评价
Acta Pharm. 2005 Sep;55(3):277-85.

引用本文的文献

1
Nanofabrication of Losartan Potassium Sustained Release Floating Microspheres using Different Grades of Ethyl Cellulose and its Insight on Release Profiles.采用不同等级乙基纤维素的氯沙坦钾控释漂浮微球的纳米制备及其对释放谱的影响。
Curr Pharm Des. 2024;30(28):2257-2265. doi: 10.2174/0113816128309675240530060752.
2
Utilizing 4D Printing to Design Smart Gastroretentive, Esophageal, and Intravesical Drug Delivery Systems.利用 4D 打印设计智能胃滞留、食管和膀胱内药物输送系统。
Adv Healthc Mater. 2023 Apr;12(10):e2202631. doi: 10.1002/adhm.202202631. Epub 2023 Jan 18.
3
Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study.
替米沙坦微球控释制剂的制备与评价:体内外研究
J Food Drug Anal. 2014 Dec;22(4):542-548. doi: 10.1016/j.jfda.2014.05.001. Epub 2014 Aug 8.
4
Risk-based approach for systematic development of gastroretentive drug delivery system.基于风险的胃滞留型药物传递系统的系统开发方法。
Drug Deliv Transl Res. 2016 Oct;6(5):579-96. doi: 10.1007/s13346-016-0315-x.